Kefah Mokbel, Chair of Breast Cancer Surgery at London Breast Institute, shared on LinkedIn about a recent paper by Frederikke Munck et al. published on Springer Nature:
“TAD is safe
The low rate of regional nodal recurrence suggests effective long-term regional control and good overall survival for patients receiving TAD without axillary lymph node dissection.”
Title: Oncologic First Events in Breast Cancer Patients After Targeted Axillary Dissection
Authors: Frederikke Munck, Maj-Britt Jensen, Riazan Hawaz-ali and Tove H. F. Tvedskov
